GOALS

TYPE AND SCOPE OF
RESEARCH

ELIGIBILITY

SUMS AVAILABLE FOR
RESEARCH GRANTS

ORIGINALITY OF RESEARCH
AND MATCHING FUNDS

TYPE OF EXPENSES ALLOWED

APPLICATION CYCLE

APPLICATION FORM AND
BUDGET

PEER-REVIEW, DECISION
AND APPEAL

ETHICAL OBLIGATIONS

ACKNOWLEDGEMENTS

CONDITIONS

ABOUT THE AHCDC

BAXTER’S PARTNERSHIP
WITH THE AHCDC

GRANT RECIPIENTS

BAXTER’S
PARTNERSHIP
WITH THE AHCDC

Since 2005 Baxter's Bioscience Business and the Association of Hemophilia Clinic Directors of Canada (AHCDC) have entered into a partnership to advance hemophilia research in Canada through support of AHCDC and some of its key infrastructures that enable large population-based research of global relevance.